恩华药业

- 002262

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
恩华药业(002262) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入447,098.88301,012.17151,088.88569,763.30414,546.31
营业收入447,098.88301,012.17151,088.88569,763.30414,546.31
二、营业总成本326,299.49223,375.93117,250.79440,387.22299,590.86
营业成本107,202.4174,524.0838,239.43150,654.09108,807.26
营业税金及附加5,567.623,884.841,879.367,529.485,409.39
销售费用141,375.1397,083.7050,832.47198,474.67125,156.99
管理费用22,359.0314,949.737,411.9825,876.1717,866.89
财务费用-1,473.56-640.99-313.41-1,712.68-1,216.66
研发费用51,268.8733,574.5719,200.9659,565.5043,566.99
资产减值损失----------
公允价值变动收益----------
投资收益4,700.983,247.962,073.256,556.864,337.60
其中:对联营企业和合营企业的投资收益892.05386.36264.332,028.93684.94
汇兑收益----------
三、营业利润124,530.5079,285.6333,860.21133,657.36117,139.34
加:营业外收入210.1892.7724.54465.40256.02
减:营业外支出1,384.96537.99251.634,453.922,155.54
其中:非流动资产处置损失----------
四、利润总额123,355.7278,840.4133,633.12129,668.84115,239.83
减:所得税费用12,903.158,834.983,569.1515,589.6113,586.11
五、净利润110,452.5870,005.4330,063.96114,079.23101,653.72
归属于母公司所有者的净利润110,604.7470,049.4730,070.57114,356.44102,010.71
少数股东损益-152.16-44.05-6.61-277.21-356.99
六、每股收益
基本每股收益(元/股)1.09000.69000.30001.13001.0100
稀释每股收益(元/股)1.09000.69000.30001.13001.0100
七、其他综合收益-------588.12--
八、综合收益总额110,452.5870,005.4330,063.96113,491.11101,653.72
归属于母公司所有者的综合收益总额110,604.7470,049.4730,070.57113,768.33102,010.71
归属于少数股东的综合收益总额-152.16-44.05-6.61-277.21-356.99
下载全部历史数据到excel中 返回页顶